OncXerna Begins Navicixizumab Phase II Basket Trial
In the signal-finding study currently enrolling colorectal and triple-negative breast cancer patients, the company will also evaluate the ability of its Xerna TME Panel to identify best responders.
Source: precisiononcologynews.com